Key TakeawaysLevi Strauss posted a stylized image resembling Beyonce's "Cowboy Carter" album cover on Instagram that may hint at a collaboration with the superstar.Levi's CEO Michelle Gass reportedly pushed back the company's goal of reaching $9 billion to $10 billion in annual revenue by 2027.The company earlier this year reported $6.2 billion in revenue for its fiscal 2023. Levi Strauss & Co. (LEVI) hinted that a collaboration with superstar Beyonce may be on the horizon in an Instagram post on Monday. Th ...

Retailers are preparing for the holiday season with as much enthusiasm as shoppers looking for great deals. The season, which accounts for a sizable chunk of yearly revenues, is a make-or-break for retailers. To make the most of the festive season and win over early-bird shoppers, Target Corporation (TGT) is back with impressive deals and expanded product offerings.Target Circle Week: The Holiday KickoffTarget kicks off the holiday festivities with Target Circle Week, running from Oct. 6-12. This week-long ...

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute MyocarditisSeptember 24, 2024 7:27 AM EDT | Source: Cardiol Therapeutics Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in the VIRAGE Phase 2b cl ...

My recommendation for MYT Netherlands Parent (NYSE: MYTE ) is a buy rating. I am positive that the strategy MYTE has employed will help it drive growth to a low 20% over the medium term. Notably, the flywheel effect that MYTEI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-t ...

I recently joined The REIT Forum and if you are looking for more investment ideas like this one, get them exclusively at The REIT Forum with access to our subscriber only portfolios.With comparable sales turning positive in Q2 FY24 after four consecutive quarters of decline and operating margins steadily rising, Target (NYSE: TGT ) is showing improving trends in its fundamentals with strength inAmrita runs a boutique family office fund in beautiful Vancouver, where she leads the investment strategy for the ...

Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial strategies and execute large-scale financings. He has also made significant efforts to institutionalize REIT framework in Latvia to boost the liquidity of pan-Baltic capital markets. Other policy-level work includes the development of national SOE financing guidelines and framework for channeling private capital into affordable housing stock. Roberts is a CFA Charterholder, ESG inves ...

Shares of Eli Lilly (NYSE: LLY ) have soared another 58% so far in 2024. The rally extends a bull market in the stock of the world’s most valuable pharmaceutical company, driven by ongoing optimism and real earnings growth due to itsFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a nar ...

FedEx (FDX) stock is spiraling Friday after the logistics giant missed top- and bottom-line expectations for its fiscal first quarter and revised its full-year outlook.In the quarter ended August 31, FedEx's revenue decreased 0.5% year-over-year to $21.6 billion and its earnings per share (EPS) plunged 20.9% from the year-ago period to $3.60.In a statement, FedEx CEO Raj Subramaniam called the quarter "challenging." However, he added that the company remained "focused on transforming our network, improving ...